SCHEMBL20127591

SCHEMBL20127591

c1cc(-c2ccc3oc4ccccc4c3c2)cc(-c2c3ccccc3c(-c3ccc4c(c3)oc3ccc5ccccc5c34)c3ccccc23)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
PLA2G2A P14555 3/20 0.40
PLA2G4A P47712 3/20 0.40
PLA2G10 O15496 1/20 0.40
AHR P35869 4/20 0.40
ABCG2 Q9UNQ0 4/20 0.40
PAX8 Q06710 2/20 0.40
CYP1A1 P04798 1/20 0.40
CYP1A2 P05177 1/20 0.40
FYN P06241 1/20 0.40
MAPK3 P27361 1/20 0.40
HCRTR1 O43613 1/20 0.38
KDM4E B2RXH2 3/20 0.38
MAPT P10636 3/20 0.38
HPGD P15428 3/20 0.38
MEN1 O00255 2/20 0.38
NPC1 O15118 2/20 0.38
ALDH1A1 P00352 2/20 0.38
RAB9A P51151 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17945175 0.95 TDP1 (0.48) TDP1L3MBTL1AHRABCG2PAX8
SCHEMBL20127589 0.94 TDP1 (0.44) TDP1L3MBTL1PLA2G2APLA2G4AAHR
SCHEMBL20127318 0.93 PLA2G2A (0.43) TDP1L3MBTL1PLA2G2APLA2G4APLA2G10
SCHEMBL22217500 0.93 TDP1 (0.47) TDP1L3MBTL1AHRABCG2PAX8
SCHEMBL10122711 0.93 ABCG2 (0.44) TDP1L3MBTL1PLA2G2APLA2G4APLA2G10
SCHEMBL25783709 0.92 ABCG2 (0.40) TDP1L3MBTL1AHRABCG2PAX8
SCHEMBL20127503 0.92 PLA2G2A (0.42) TDP1L3MBTL1PLA2G2APLA2G4APLA2G10
SCHEMBL20127588 0.92 ABCG2 (0.42) TDP1L3MBTL1PLA2G2APLA2G4APLA2G10
SCHEMBL20127580 0.92 TDP1 (0.50) TDP1L3MBTL1AHRABCG2PAX8
SCHEMBL12338264 0.91 TDP1 (0.41) TDP1L3MBTL1PLA2G2APLA2G4APLA2G10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 TDP1 3427/4885L3MBTL1 1670/4885PLA2G2A 2960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.